Skip to main content
Clinical Trials/CTRI/2022/03/041059
CTRI/2022/03/041059
Not yet recruiting
Phase 1

The 90% Effective Dose (ED 90) of 0.75% Intrathecal Ropivacaine for Day Care Surgery in Patients Undergoing Lower Abdominal, Inguinal and Urological Surgery- Estimation with the Biased Coin Up-and-Down Sequential Method

AIIMS New Delhi0 sites0 target enrollmentStarted: TBDLast updated:

Overview

Phase
Phase 1
Status
Not yet recruiting
Sponsor
AIIMS New Delhi

Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1\. Consenting patients scheduled to undergo day care surgery
  • 2\. Age 18\-60 Years
  • 3\. Height: 160 cm â?? 175 cm
  • 4\. Male patients
  • 5\. Weight: 50\-80 Kg
  • 6\. ASA 1 and 2

Exclusion Criteria

  • \-Spinal abnormalities
  • \-Surgeries expected to exceed a duration of 2 hours
  • \-Infection at the site of spinal injection
  • \-Coagulopathies
  • \-Allergy to amide local anesthetics
  • \-Long standing diabetics

Investigators

Sponsor
AIIMS New Delhi

Similar Trials